<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03196973</url>
  </required_header>
  <id_info>
    <org_study_id>DF289OT3-16IA01</org_study_id>
    <nct_id>NCT03196973</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa</brief_title>
  <official_title>A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Salvat</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Salvat</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a combination of an antibiotic plus a
      corticosteroid is safe and effective in treating AOE
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Therapeutic cure (Clinical + Microbiological cure)</measure>
    <time_frame>End of Treatment (Day 8+2)</time_frame>
    <description>Therapeutic cure will be considered achieved if edema, otalgia and otorrhea are resolved with no further requirement of antimicrobial therapy and bacteriological response is Eradication or Presumed Eradication</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to End of Pain</measure>
    <time_frame>From baseline to End of Study (Day 15+2)</time_frame>
    <description>First day on which there is no use of analgesics, the pain score is zero and remains zero until end of study</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acute Otitis Externa</condition>
  <arm_group>
    <arm_group_label>DF289 plus DF277</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Otic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DF289</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Otic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DF277</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Otic solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DF289 plus DF277</intervention_name>
    <description>1 vial into the affected ear twice daily for 7 days</description>
    <arm_group_label>DF289 plus DF277</arm_group_label>
    <other_name>Antibiotic and Corticosteroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DF289</intervention_name>
    <description>1 vial into the affected ear twice daily for 7 days</description>
    <arm_group_label>DF289</arm_group_label>
    <other_name>Antibiotic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DF277</intervention_name>
    <description>1 vial into the affected ear twice daily for 7 days</description>
    <arm_group_label>DF277</arm_group_label>
    <other_name>Corticosteroid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uncomplicated AOE of less tan 21 days, defined as a total symptom score of at least 2
             for otalgia, 2 for edema and 1 for otorrhea

          -  Brighton Grading of II or III

          -  Culture-based diagnosis of acute bacterial otitis externa

          -  Willingness to refrain from swimming through end of the study

        Exclusion Criteria:

          -  Previous episode of AOE within 4 weeks prior to enrollment, or 2 or more episodes of
             AOE within 6 months prior to the enrollment.

          -  Tympanic membrane perforation

          -  Any condition or situation likely to cause the patient to be unable or unwilling to
             comply with study treatment or attend all study visits

          -  Any condition in the patient or parent/guardian that, in the judgment of the principal
             investigator, could compromise patient safety, limit the patient's ability to complete
             the study, and/or compromise the objectives of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrique Jim√©nez</last_name>
    <role>Study Director</role>
    <affiliation>Salvat</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enrique Jimenez, MD</last_name>
    <phone>+34 933946400</phone>
    <email>ejimenezv@salvatbiotech.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Lois</last_name>
    <email>plois@salvatbiotech.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laboratorios SALVAT</name>
      <address>
        <city>Esplugues de Llobregat</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Jimenez, MD</last_name>
      <phone>+34933946400</phone>
      <email>clinicaltrials@salvatbiotech.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2017</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Externa</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

